Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Winter

Showing results (211-220 of 214) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 214 results.
Epilepsia|August 9, 2024
Mitigating treatment lag for infantile epileptic spasms syndrome in low- and middle-income countries: Key recommendations from the South Asia allied IESS Research GroupJitendra Kumar Sahu, Priyanka Madaan, Jithangi Wanigasinghe, et al.
Neuro-Oncology|July 4, 2023
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cellsPhilipp Karschnia, Isabel C Arrillaga-Romany, April Eichler, et al.
The Lancet. Global Health|March 14, 2024
National plans and awareness campaigns as priorities for achieving global brain healthSebastian F Winter, Donna Walsh, Coriene Catsman-Berrevoets, et al.
BMC Medicine|December 5, 2024
Clinical research framework proposal for ketogenic metabolic therapy in glioblastomaTomás Duraj, Miriam Kalamian, Giulio Zuccoli, et al.
Pageof 22

Showing results (211-220 of 214) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 214 results.
Epilepsia|August 9, 2024
Mitigating treatment lag for infantile epileptic spasms syndrome in low- and middle-income countries: Key recommendations from the South Asia allied IESS Research GroupJitendra Kumar Sahu, Priyanka Madaan, Jithangi Wanigasinghe, et al.
Neuro-Oncology|July 4, 2023
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cellsPhilipp Karschnia, Isabel C Arrillaga-Romany, April Eichler, et al.
The Lancet. Global Health|March 14, 2024
National plans and awareness campaigns as priorities for achieving global brain healthSebastian F Winter, Donna Walsh, Coriene Catsman-Berrevoets, et al.
BMC Medicine|December 5, 2024
Clinical research framework proposal for ketogenic metabolic therapy in glioblastomaTomás Duraj, Miriam Kalamian, Giulio Zuccoli, et al.
Pageof 22